The Human Papillomavirus (HPV) CERVAVAC vaccine, for the prevention of cervical cancer, is expected to arrive in India by April at the one-tenth of the cost of internationally branded vaccines in the country, said Dr NK Arora, chairman of the Covid working group, National Technical Advisory Group on Immunisation (NTAGI), on Tuesday.
We will finalise it after manufacturing and discussion with the Government of India,” said Adar Poonawalla. New Delhi: India’s first indigenously developed quadrivalent Human Papilloma Virus (qHPV) vaccine will be available at an affordable price, said Serum Institute of India (SII) CEO Adar Poonawala on Thursday. “The vaccine for cervical...
The post appeared first on .
We will finalise it after manufacturing and discussion with the Government of India,” said Adar Poonawalla. New Delhi: India’s first indigenously developed quadrivalent Human Papilloma Virus (qHPV) vaccine will be available at an affordable price, said Serum Institute of India (SII) CEO Adar Poonawala on Thursday. “The vaccine for cervical...
The post appeared first on .
We will finalise it after manufacturing and discussion with the Government of India,” said Adar Poonawalla. New Delhi: India’s first indigenously developed quadrivalent Human Papilloma Virus (qHPV) vaccine will be available at an affordable price, said Serum Institute of India (SII) CEO Adar Poonawala on Thursday. “The vaccine for cervical...
The post appeared first on .
We will finalise it after manufacturing and discussion with the Government of India,” said Adar Poonawalla. New Delhi: India’s first indigenously developed quadrivalent Human Papilloma Virus (qHPV) vaccine will be available at an affordable price, said Serum Institute of India (SII) CEO Adar Poonawala on Thursday. “The vaccine for cervical...
The post appeared first on .
We will finalise it after manufacturing and discussion with the Government of India,” said Adar Poonawalla. New Delhi: India’s first indigenously developed quadrivalent Human Papilloma Virus (qHPV) vaccine will be available at an affordable price, said Serum Institute of India (SII) CEO Adar Poonawala on Thursday. “The vaccine for cervical...
The post appeared first on .
We will finalise it after manufacturing and discussion with the Government of India,” said Adar Poonawalla. New Delhi: India’s first indigenously developed quadrivalent Human Papilloma Virus (qHPV) vaccine will be available at an affordable price, said Serum Institute of India (SII) CEO Adar Poonawala on Thursday. “The vaccine for cervical...
The post appeared first on .
We will finalise it after manufacturing and discussion with the Government of India,” said Adar Poonawalla. New Delhi: India’s first indigenously developed quadrivalent Human Papilloma Virus (qHPV) vaccine will be available at an affordable price, said Serum Institute of India (SII) CEO Adar Poonawala on Thursday. “The vaccine for cervical...
The post appeared first on .
New Delhi [India], June 9 (ANI): Highlighting the potential of bio start-ups and bio-professionals in India, Prime Minister Narendra Modi on Thursday said India's diverse population and climatic zones are among the top factors behind the growth of the country's biotech industry.